464109879	464109879	CD	B-NP	O
|	|	NN	I-NP	O
BHMH	BHMH	NN	I-NP	O
|	|	NN	I-NP	O
29069517	29069517	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3001570	3001570	CD	B-NP	O
|	|	CC	I-NP	O
7/7/2006	7/7/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
diastolic	diastolic	JJ	I-NP	I-protein
dysfunction-chf	dysfunction-chf	JJ	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/13/2006	8/13/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/16/2006	10/16/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
AMANCIO	AMANCIO	NNP	B-NP	O
,	,	,	O	O
LEOPOLDO	LEOPOLDO	NNP	B-NP	O
386-98-18-5	386-98-18-5	CD	I-NP	O
Tari	Tari	NNP	I-NP	O
U	U	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/10/06	7/10/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ERRINGTON	ERRINGTON	NNP	B-NP	O
,	,	,	O	O
GREGG	GREGG	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Give	Give	NNP	I-NP	O
at	at	IN	B-PP	O
Discharge	Discharge	NNP	B-NP	O
Instructions	Instructions	NNP	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	B-protein
's	's	POS	B-NP	I-protein
home	home	NN	I-NP	I-protein
med-has	med-has	JJ	I-NP	I-protein
prescription	prescription	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
GLUCONATE	GLUCONATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
BUOHC	BUOHC	NNP	B-NP	B-cell_type
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
by	by	IN	B-PP	O
STRASSER	STRASSER	NN	B-NP	O
,	,	,	O	O
TOD	TOD	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
by	by	IN	B-PP	O
MALLINGER	MALLINGER	NNP	B-NP	O
,	,	,	O	O
OSVALDO	OSVALDO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
170907436	170907436	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/28/06	5/28/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pts	pt	NNS	B-NP	O
home	home	NN	I-NP	O
med	me	VBD	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/27/06	8/27/06	CD	B-NP	O
by	by	IN	B-PP	O
SCHLEGEL	SCHLEGEL	NNP	B-NP	O
,	,	,	O	O
SAMUEL	SAMUEL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
701631300	701631300	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/9	11/9	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
PAXIL	PAXIL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PAROXETINE	PAROXETINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP-Dr	PCP-Dr	NN	B-NP	O
.	.	.	O	O

Bussard	Bussard	NNP	B-NP	O
10/10/06	10/10/06	CD	I-NP	O
,	,	,	O	O
Cardiologist-Dr	Cardiologist-Dr	NNP	B-NP	O
.	.	.	O	O

Mercik	Mercik	NNP	B-NP	O
8/18/06	8/18/06	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Lightheadedness/shortness	Lightheadedness/shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction-chf	dysfunction-chf	JJ	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
tobacco	tobacco	NN	I-NP	O
,	,	,	O	O
anxiety	anxiety	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Stress	Stress	NNP	I-NP	O
Test	Test	NNP	I-NP	O
with	with	IN	B-PP	O
Oximetry	Oximetry	NNP	B-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
status	status	NN	I-NP	O
Echo	Echo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TTE	TTE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Lightheadness	Lightheadness	NN	B-NP	O
and	and	CC	I-NP	O
DOE	DOE	NN	I-NP	O
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
78	78	CD	B-NP	O
y.o	y.o	NN	I-NP	O
female	female	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
hx	hx	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
in	in	IN	B-PP	O
4/25	4/25	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
LIMA	LIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
LM1	LM1	NN	B-NP	B-protein
and	and	CC	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
intermittent	intermittent	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
DOE	DOE	NNP	B-NP	O
,	,	,	O	O
extending	extend	VBG	B-VP	O
back	back	RP	B-PRT	O
before	before	IN	B-PP	O
her	her	PRP$	B-NP	O
CABG	CABG	NN	I-NP	B-protein
,	,	,	O	O
usually	usually	RB	B-ADJP	O
exertional	exertional	JJ	I-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
however	however	RB	B-ADVP	O
she	she	PRP	B-NP	O
tends	tend	VBZ	B-VP	O
to	to	TO	I-VP	O
hyperventilate	hyperventilate	VB	I-VP	O
during	during	IN	B-PP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
which	which	WDT	B-NP	O
makes	make	VBZ	B-VP	O
her	her	PRP	B-NP	O
lightheaded	lightheade	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
vison/hearing	vison/hearing	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
episodes	episode	NNS	I-NP	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
increasing	increase	VBG	I-VP	O
in	in	IN	B-PP	O
frequency	frequency	NN	B-NP	O
occuring	occur	VBG	B-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-VP	O
4x/day	4x/day	VB	I-VP	O
but	but	CC	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
temporal	temporal	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
while	while	IN	B-SBAR	O
going	go	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	B-DNA
,	,	,	O	I-DNA
BP	BP	NN	B-NP	I-DNA
148/67	148/67	CD	I-NP	I-DNA
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
72	72	CD	I-NP	I-protein
,	,	,	O	O
SaO2	SaO2	NN	B-NP	O
94	94	CD	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

*************	*************	SYM	B-NP	B-protein
PMH	PMH	NN	I-NP	I-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
4/25	4/25	CD	B-NP	O
LIMA	LIMA	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	O	O
OM	OM	NN	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	B-protein
-	-	HYPH	O	O
>	>	SYM	O	O
PDA	PDA	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

hyperlipidemia	hyperlipidemia	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

anxiety	anxiety	NN	B-NP	O
****	****	SYM	I-NP	O
Meds	Med	NNS	I-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325mg	325mg	NN	I-NP	O
qd	qd	NN	I-NP	O
Toprol	Toprol	NNP	I-NP	O
xl	xl	NNP	I-NP	O
25mg	25mg	NN	I-NP	O
qd	qd	NN	I-NP	O
lasix	lasix	NN	I-NP	O
20mg	20mg	CD	I-NP	O
qd	qd	NN	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
5mg	5mg	CD	I-NP	O
qd	qd	NN	I-NP	O
paxil	paxil	NN	I-NP	O
20mg	20mg	CD	I-NP	O
qd	qd	NN	I-NP	O
****	****	SYM	B-ADJP	O
All	All	DT	O	O
:	:	:	O	O
pcn-anaphylaxis	pcn-anaphylaxis	NN	B-NP	O
****	****	SYM	O	O
FH	FH	NN	B-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
cad	cad	NN	I-NP	O
****	****	SYM	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
pcp	pcp	NN	B-NP	O
:	:	:	O	O
dr.	dr.	NN	B-NP	O
bault	bault	NN	I-NP	O
,	,	,	O	O
/	/	SYM	B-NP	B-protein
cardiologist	cardiologist	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
dr.	dr.	NN	I-NP	I-protein
petraglia	petraglia	NN	I-NP	I-protein
,	,	,	O	O
****	****	SYM	B-NP	B-protein
Px	Px	NN	I-NP	I-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
VSS-bp	VSS-bp	NN	I-NP	O
:	:	:	O	O
128/72	128/72	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
,	,	,	I-NP	O
so2	so2	CD	I-NP	O
:	:	:	O	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
well-nourished	well-nourished	JJ	B-NP	O
female	female	JJ	I-NP	O
lying	lying	NN	I-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
rrr	rrr	NN	B-NP	B-protein
s1/s2	s1/s2	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
mrg	mrg	NN	I-NP	O
resp	resp	NN	I-NP	O
:	:	:	O	O
ctab	ctab	NN	B-NP	O
abd	abd	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
non-tender	non-tender	JJ	I-NP	O
+	+	JJ	I-NP	O
bs	b	NNS	I-NP	O
ext	ext	VBP	B-VP	O
:	:	:	O	O
warm	warm	NN	B-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
edema	edema	NN	I-NP	O
*****	*****	SYM	B-NP	O
Labs	Lab	NNPS	I-NP	O
:	:	:	O	O
wbc	wbc	NN	B-NP	O
:	:	:	O	O
9.1	9.1	CD	B-NP	O
,	,	,	O	O
hb	hb	NN	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
:	:	:	O	O
35.4	35.4	CD	B-NP	O
,	,	,	O	O
plt	plt	NN	B-NP	O
:	:	:	O	O
280	280	CD	B-NP	O
MCV	MCV	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-ADJP	O
at	at	IN	B-PP	O
76.5-79	76.5-79	CD	B-NP	O
.5	.5	CD	I-NP	O
Romi	Romi	NNP	I-NP	O
x	x	CC	O	O
3	3	CD	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	I-NP	O
trop	trop	NN	I-NP	O
<	<	SYM	I-NP	O
assay	assay	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
infralateral	infralateral	JJ	I-NP	O
t	t	NN	I-NP	O
wave	wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
*****	*****	SYM	I-NP	O
HOSPITAL	HOSPITAL	JJ	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
romi	romi	NN	B-NP	O
x3	x3	NN	I-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
kept	keep	VBD	B-VP	O
on	on	IN	B-PP	O
tele-however	tele-however	RB	B-NP	O
no	no	DT	I-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
stress	stress	NN	B-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
oximetry	oximetry	NN	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
3/2	3/2	CD	B-NP	O
,	,	,	O	O
echo	echo	NN	B-NP	O
4/12	4/12	CD	I-NP	O
showed	show	VBD	B-VP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
HTN	HTN	NN	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
increased	increase	VBN	I-NP	O
bp	bp	NN	I-NP	O
readings	reading	NNS	I-NP	O
160/90	160/90	CD	B-NP	O
;	;	:	O	O
increased	increase	VBN	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
to	to	TO	B-PP	O
15mg	15mg	CD	B-NP	O
on	on	IN	B-PP	O
10/3	10/3	CD	B-NP	O
goal	goal	NN	I-NP	O
bp	bp	NN	I-NP	O
was	be	VBD	B-VP	O
<	<	JJR	B-ADJP	O
130/80	130/80	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
TSH	TSH	NN	I-NP	O
low	low	JJ	B-ADJP	O
at	at	IN	B-PP	O
0.439	0.439	CD	B-NP	O
,	,	,	O	O
t4/t3	t4/t3	NN	B-NP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
hba1c	hba1c	NN	B-NP	O
:	:	:	O	O
elevated	elevate	VBN	B-VP	O
8.2	8.2	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

PSYCH	PSYCH	NN	B-NP	B-protein
-	-	HYPH	B-PP	O
continued	continue	VBN	B-NP	O
paxil	paxil	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
added	add	VBN	I-VP	O
ativan	ativan	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
prn	prn	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
mcv	mcv	NN	B-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
fe	fe	JJ	B-ADJP	O
:	:	:	O	O
39	39	CD	B-NP	O
low	low	JJ	I-NP	O
,	,	,	I-NP	O
tibc	tibc	NN	I-NP	O
365	365	CD	I-NP	O
ferritin	ferritin	NN	I-NP	O
85	85	CD	I-NP	O
;	;	:	O	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
--	--	:	O	O
given	give	VBN	B-PP	O
ferrous	ferrous	JJ	B-NP	O
gluconate/colace	gluconate/colace	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
-	-	HYPH	B-PP	O
full	full	JJ	B-NP	O
****	****	SYM	I-NP	O
Discharge	Discharge	NN	I-NP	O
px	px	NN	I-NP	O
:	:	:	O	O
VSS	VSS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
:	:	:	O	O
97.8	97.8	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
:	:	:	O	O
60-82	60-82	CD	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
:	:	:	O	O
138-160/72	138-160/72	CD	B-NP	O
-92	-92	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
130/70	130/70	CD	I-NP	O
SO2	SO2	NN	I-NP	O
:	:	:	O	O
95-100	95-100	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Discharge	Discharge	NNP	I-NP	O
Labs	Labs	NNP	I-NP	O
:	:	:	O	O
na	na	NN	B-NP	O
:	:	:	O	O
142	142	CD	B-NP	O
,	,	,	O	O
k	k	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

O	O	NN	B-NP	O
,	,	,	O	O
cl	cl	NN	B-NP	O
:	:	:	O	O
107	107	CD	B-NP	O
,	,	,	O	O
co2	co2	NN	B-NP	O
:	:	:	O	O
26	26	CD	B-NP	O
,	,	,	O	O
Bun	Bun	NNP	B-NP	O
:	:	:	O	O
19	19	CD	B-NP	O
,	,	,	O	O
creat	creat	NN	B-NP	O
:	:	:	O	O
0.8	0.8	CD	B-NP	O
wbc	wbc	NN	I-NP	O
:	:	:	O	O
10.5	10.5	CD	B-NP	O
,	,	,	O	O
hb	hb	NN	B-NP	O
:	:	:	O	O
11.8	11.8	CD	B-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
:	:	:	O	O
35.8	35.8	CD	B-NP	O
,	,	,	O	O
plt	plt	NN	B-NP	O
:	:	:	O	O
297	297	CD	B-NP	O
,	,	,	O	O
mcv	mcv	NN	B-NP	O
:	:	:	O	O
78.0	78.0	CD	B-NP	O
alkp	alkp	NN	I-NP	O
:	:	:	O	O
120	120	CD	B-NP	O
ADDITIONAL	ADDITIONAL	JJ	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Dinwoodie	Dinwoodie	NNP	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasure	pleasure	NN	I-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
care	care	NN	B-NP	O
of	of	IN	B-PP	O
you	you	PRP	B-NP	O
during	during	IN	B-PP	O
your	your	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
made	make	VBN	I-VP	O
some	some	DT	B-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
increased	increase	VBD	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medication	medication	NN	I-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
from	from	IN	B-PP	O
5mg	5mg	CD	B-NP	O
to	to	TO	B-PP	O
15mg	15mg	CD	B-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
started	start	VBD	B-VP	O
you	you	PRP	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
medication	medication	NN	I-NP	O
for	for	IN	B-PP	O
anemia	anemia	NN	B-NP	O
:	:	:	O	O
ferrous	ferrous	JJ	B-NP	O
gluconate	gluconate	NN	I-NP	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
colace	colace	NN	B-NP	O
a	a	DT	B-NP	O
stool	stool	NN	I-NP	O
softener	softener	NN	I-NP	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
frm	frm	NN	I-NP	O
20mg	20mg	NN	I-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
40mg	40mg	VB	I-VP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
discussed	discuss	VBN	B-VP	O
with	with	IN	B-PP	O
you	you	PRP	B-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
abnormality	abnormality	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
functioning	functioning	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
explain	explain	VB	B-VP	O
your	your	PRP$	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
especially	especially	RB	B-ADVP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
extremely	extremely	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Clague	Clague	NNP	I-NP	O
appt	appt	NN	I-NP	O
7/12	7/12	CD	I-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
pm	pm	NN	I-NP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Dodgen	Dodgen	NNP	I-NP	O
on	on	IN	B-PP	O
2/16	2/16	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
pm	pm	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
trouble	trouble	NN	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
please	please	NN	I-NP	O
seek	seek	VBP	B-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
f/u	f/u	NN	B-NP	O
tsh	tsh	NN	I-NP	O
,	,	,	O	O
t4/t3	t4/t3	NN	B-NP	O
,	,	,	O	O
hba1c	hba1c	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
;	;	:	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
hyperglycemic	hyperglycemic	JJ	B-NP	O
agent	agent	NN	I-NP	O
f/u	f/u	NN	I-NP	O
iron	iron	NN	I-NP	O
studies	study	NNS	I-NP	O
mcv	mcv	VBP	B-VP	O
f/u	f/u	NN	B-NP	O
alk	alk	NN	I-NP	O
phos	pho	NNS	I-NP	O
Event	Event	NN	I-NP	O
monitor	monitor	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
to	to	TO	I-VP	O
pt	pt	VB	I-VP	O
in	in	IN	B-PP	O
7-10	7-10	CD	B-NP	O
business	business	NN	I-NP	O
days	day	NNS	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VOORHIS	VOORHIS	NNP	B-NP	O
,	,	,	O	O
ISAAC	ISAAC	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RZ46	RZ46	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/10/06	7/10/06	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

